These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prostaglandin F2alpha regulates distinct physiological changes in early and mid-cycle bovine corpora lutea.
    Author: Tsai SJ, Wiltbank MC.
    Journal: Biol Reprod; 1998 Feb; 58(2):346-52. PubMed ID: 9475388.
    Abstract:
    Prostaglandin (PG) F2alpha is the primary luteolysin in most species. A single treatment with PGF2alpha will cause regression of the mid-cycle but not the early-cycle (Days 1-5 after estrus) bovine corpus luteum (CL) despite the presence of similar concentrations of high-affinity PGF2alpha receptors (FP receptors). This study was designed to determine whether PGF2alpha activated similar intracellular processes in early- and mid-cycle CL. Cows received saline or 25 mg PGF2alpha injection (i.m.; n = 6/group) on Day 4 or 11 after onset of the LH surge (induced by GnRH injection), and CL were collected at 4 h after treatment. As expected, CL volumes and luteal weights were not different at 4 h after PGF2alpha treatment. Luteal vitamin C concentration and steady-state concentrations of mRNA for 3beta-hydroxysteroid dehydrogenase and for FP receptor were decreased by 4 h in both Day 4 and 11 CL treated with PGF2alpha (p < 0.05). These results demonstrate clear actions of PGF2alpha in the early CL. In contrast, steady-state concentrations of mRNA encoding PG G/H synthase-2 (PGHS-2) were increased by treatment with PGF2alpha in mid-cycle CL but decreased by PGF2alpha in early-cycle CL (p < 0.05). In addition, treatment of mid-cycle but not early-cycle cows with PGF2alpha decreased luteal and serum progesterone concentrations by 4 h (p < 0.05). In summary, PGF2alpha clearly exerts actions in both early- and mid-cycle bovine CL. The lack of PGF2alpha-induced luteolysis in the early CL may be due to specific changes in gene expression, especially PGHS-2, that may prevent intraluteal PGF2alpha production and possibly other key luteolytic processes.
    [Abstract] [Full Text] [Related] [New Search]